A court ruling requires mifepristone to be distributed only in-person at clinics, overturning FDA regulations. The decision is expected to be appealed to the U.S. Supreme Court, potentially reshaping medication access policies.

The U.S. Supreme Court's decision in Louisiana v. Callais significantly weakens federal Voting Rights Act protections, allowing states greater latitude in redrawing congressional districts. This ruling has sweeping consequences for district line drawing at all government levels and could trigger substantial redistricting changes nationwide.